Fig. 6: The ability of LacAC4A to promote wound healing infected by MDR PA in vivo. | Nature Communications

Fig. 6: The ability of LacAC4A to promote wound healing infected by MDR PA in vivo.

From: Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer

Fig. 6

a Scheme of the therapeutic process of MDR PA-infected diabetic wound healing. b Representative images of wound change in diabetic rats infected with MDR PA after treatments. Scale bar was 1.0 cm. c Traces of wound-bed closure in diabetic rats infected with MDR PA after treatments. d Wound area changes in MDR PA infected diabetic rats after treatments. e Representative images of bacteria colonies remaining in wounds of diabetic rats infected with MDR PA after treatments. f Remaining bacterial changes in MDR PA infected diabetic rats after treatments. g Changes in body weight of rats after various treatments. Data are presented as mean ± SD, n = 5, *p < 0.05, **p < 0.01, ***p < 0.001.

Back to article page